Agenus IncNASDAQ:AGEN
- LAST PRICE4.5300
- TODAY'S CHANGE (%)0.2800 (6.5882%)
- Bid / Lots4.4100/ 1
- Ask / Lots4.5400/ 3
- Open / Previous Close4.2600 / 4.2500
- Day Range
- 52 Week Range
- Volume264,193
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AGEN |
|---|---|---|
| 09:32 ET | 4221 | 4.25 |
| 09:34 ET | 4444 | 4.25 |
| 09:36 ET | 2900 | 4.245 |
| 09:38 ET | 1047 | 4.23 |
| 09:39 ET | 207 | 4.22 |
| 09:41 ET | 1513 | 4.22 |
| 09:43 ET | 3933 | 4.285 |
| 09:45 ET | 2979 | 4.3 |
| 09:48 ET | 2895 | 4.29 |
| 09:50 ET | 254 | 4.27 |
| 09:52 ET | 635 | 4.28 |
| 09:54 ET | 250 | 4.31 |
| 09:56 ET | 1046 | 4.3116 |
| 09:57 ET | 100 | 4.32 |
| 09:59 ET | 1300 | 4.33 |
| 10:01 ET | 150 | 4.3405 |
| 10:06 ET | 1406 | 4.391 |
| 10:08 ET | 4367 | 4.39 |
| 10:10 ET | 950 | 4.395 |
| 10:12 ET | 5331 | 4.385 |
| 10:14 ET | 100 | 4.375 |
| 10:15 ET | 658 | 4.39 |
| 10:17 ET | 200 | 4.39 |
| 10:21 ET | 1100 | 4.385 |
| 10:24 ET | 2131 | 4.37 |
| 10:26 ET | 2478 | 4.37 |
| 10:30 ET | 200 | 4.36 |
| 10:32 ET | 100 | 4.35 |
| 10:33 ET | 2822 | 4.3563 |
| 10:35 ET | 304 | 4.36 |
| 10:37 ET | 486 | 4.375 |
| 10:42 ET | 1200 | 4.4 |
| 10:44 ET | 426 | 4.4159 |
| 10:46 ET | 200 | 4.41 |
| 10:48 ET | 350 | 4.415 |
| 10:51 ET | 2984 | 4.45 |
| 10:53 ET | 900 | 4.45 |
| 10:55 ET | 1192 | 4.47 |
| 10:57 ET | 900 | 4.47 |
| 11:00 ET | 550 | 4.47 |
| 11:02 ET | 763 | 4.46 |
| 11:04 ET | 1600 | 4.47 |
| 11:06 ET | 500 | 4.463909 |
| 11:08 ET | 700 | 4.47 |
| 11:09 ET | 150 | 4.48 |
| 11:11 ET | 1203 | 4.48 |
| 11:13 ET | 600 | 4.49 |
| 11:18 ET | 100 | 4.49 |
| 11:20 ET | 1191 | 4.475 |
| 11:22 ET | 8937 | 4.5001 |
| 11:26 ET | 300 | 4.505 |
| 11:27 ET | 300 | 4.51 |
| 11:29 ET | 200 | 4.51 |
| 11:31 ET | 300 | 4.54 |
| 11:33 ET | 300 | 4.54 |
| 11:36 ET | 1400 | 4.5401 |
| 11:38 ET | 2550 | 4.5316 |
| 11:40 ET | 100 | 4.54 |
| 11:42 ET | 200 | 4.53 |
| 11:44 ET | 348 | 4.54 |
| 11:45 ET | 645 | 4.54 |
| 11:47 ET | 510 | 4.5203 |
| 11:51 ET | 200 | 4.535 |
| 11:56 ET | 215 | 4.54 |
| 11:58 ET | 100 | 4.53 |
| 12:00 ET | 400 | 4.54 |
| 12:02 ET | 600 | 4.5201 |
| 12:07 ET | 300 | 4.5 |
| 12:09 ET | 4224 | 4.4707 |
| 12:12 ET | 1500 | 4.47 |
| 12:16 ET | 500 | 4.48 |
| 12:18 ET | 602 | 4.495 |
| 12:20 ET | 200 | 4.495 |
| 12:21 ET | 100 | 4.48 |
| 12:23 ET | 500 | 4.4805 |
| 12:27 ET | 500 | 4.48 |
| 12:32 ET | 481 | 4.505 |
| 12:34 ET | 100 | 4.49 |
| 12:39 ET | 775 | 4.4745 |
| 12:41 ET | 538 | 4.48 |
| 12:43 ET | 1189 | 4.49 |
| 12:45 ET | 100 | 4.49 |
| 12:52 ET | 1400 | 4.485 |
| 12:56 ET | 500 | 4.481 |
| 12:57 ET | 450 | 4.48 |
| 12:59 ET | 994 | 4.49 |
| 01:01 ET | 200 | 4.49 |
| 01:08 ET | 600 | 4.485 |
| 01:10 ET | 300 | 4.49 |
| 01:12 ET | 700 | 4.49 |
| 01:17 ET | 100 | 4.485 |
| 01:21 ET | 100 | 4.485 |
| 01:24 ET | 300 | 4.4809 |
| 01:26 ET | 1006 | 4.51 |
| 01:28 ET | 1100 | 4.5 |
| 01:30 ET | 584 | 4.5093 |
| 01:32 ET | 144 | 4.5112 |
| 01:33 ET | 7000 | 4.5101 |
| 01:35 ET | 100 | 4.515 |
| 01:39 ET | 3303 | 4.505 |
| 01:42 ET | 414 | 4.51 |
| 01:44 ET | 1627 | 4.51 |
| 01:46 ET | 978 | 4.5014 |
| 01:48 ET | 525 | 4.51 |
| 01:51 ET | 100 | 4.505 |
| 01:53 ET | 1100 | 4.505 |
| 01:55 ET | 450 | 4.51 |
| 01:57 ET | 400 | 4.52 |
| 02:02 ET | 250 | 4.52 |
| 02:04 ET | 200 | 4.52 |
| 02:06 ET | 100 | 4.52 |
| 02:09 ET | 602 | 4.52 |
| 02:11 ET | 707 | 4.54 |
| 02:13 ET | 1880 | 4.5401 |
| 02:15 ET | 2630 | 4.55 |
| 02:18 ET | 450 | 4.535 |
| 02:20 ET | 619 | 4.54 |
| 02:22 ET | 900 | 4.56 |
| 02:26 ET | 200 | 4.565 |
| 02:27 ET | 200 | 4.575 |
| 02:31 ET | 200 | 4.58 |
| 02:33 ET | 1300 | 4.59 |
| 02:36 ET | 745 | 4.585 |
| 02:38 ET | 600 | 4.5802 |
| 02:40 ET | 100 | 4.575 |
| 02:42 ET | 1000 | 4.585 |
| 02:44 ET | 300 | 4.5865 |
| 02:45 ET | 200 | 4.58 |
| 02:47 ET | 350 | 4.58 |
| 02:49 ET | 100 | 4.5812 |
| 02:51 ET | 100 | 4.585 |
| 02:54 ET | 100 | 4.58 |
| 02:58 ET | 300 | 4.5847 |
| 03:00 ET | 683 | 4.575 |
| 03:02 ET | 1176 | 4.5799 |
| 03:03 ET | 141 | 4.575 |
| 03:05 ET | 300 | 4.575 |
| 03:07 ET | 1972 | 4.5605 |
| 03:09 ET | 1300 | 4.5739 |
| 03:12 ET | 1094 | 4.5603 |
| 03:18 ET | 1306 | 4.5601 |
| 03:20 ET | 1799 | 4.56 |
| 03:21 ET | 3691 | 4.545 |
| 03:23 ET | 200 | 4.545 |
| 03:27 ET | 539 | 4.545 |
| 03:30 ET | 415 | 4.54 |
| 03:32 ET | 600 | 4.545 |
| 03:34 ET | 2968 | 4.555 |
| 03:36 ET | 565 | 4.555 |
| 03:38 ET | 886 | 4.554 |
| 03:39 ET | 829 | 4.545 |
| 03:41 ET | 288 | 4.545 |
| 03:43 ET | 675 | 4.535 |
| 03:45 ET | 463 | 4.535 |
| 03:48 ET | 500 | 4.525 |
| 03:50 ET | 500 | 4.525 |
| 03:52 ET | 797 | 4.525 |
| 03:54 ET | 8262 | 4.525 |
| 03:56 ET | 1528 | 4.525 |
| 03:57 ET | 2297 | 4.525 |
| 03:59 ET | 27015 | 4.53 |
Today
ROSEN, A LEADING LAW FIRM, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AGEN, from 2 hours ago by Dow Jones
2 hours ago by Dow JonesAgenus Inc Is Being Sued For Possible Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm, from 4 hours ago by Dow Jones
4 hours ago by Dow Jones
Yesterday
Contact Levi & Korsinsky by November 5, 2024 Deadline to Join Class Action Against Agenus Inc. (AGEN), from 2:15PM ET on Friday Oct 11, 2024 by Dow Jones
2:15PM ET on Friday Oct 11, 2024 by Dow JonesROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AGEN, from 1:56PM ET on Friday Oct 11, 2024 by Dow Jones
1:56PM ET on Friday Oct 11, 2024 by Dow JonesShareholders That Lost Money on Agenus Inc. (AGEN) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More, from 12:30PM ET on Friday Oct 11, 2024 by Dow Jones
12:30PM ET on Friday Oct 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Agenus Inc | 97.7M | -0.4x | --- |
Karyopharm Therapeutics Inc | 107.4M | -1.0x | --- |
FibroGen Inc | 35.9M | -0.2x | --- |
Sangamo Therapeutics Inc | 174.3M | -0.6x | --- |
Seres Therapeutics Inc | 122.9M | -0.7x | --- |
Sutro Biopharma Inc | 310.6M | -2.1x | --- |
Company Information
Agenus Inc. is an immuno-oncology (I-O) company targeting cancer and infectious diseases with a pipeline of immunological agents. It is specialized in developing therapies to activate the body's immune system against cancer and infections. Its pipeline includes immune-modulatory antibodies, adoptive cell therapies (via MiNK Therapeutics, Inc.), and vaccine adjuvants (via SaponiQx, Inc.). Its primary focus is I-O, and its diverse pipeline is supported by its in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. Its most advanced antibody candidates are botensilimab (a multifunctional immune cell activator and human Fc-enhanced cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody (AGEN1811)) and balstilimab (a programmed death receptor-1 (PD-1) blocking antibody). Its pipeline includes several classes of immunotherapies: checkpoint inhibitors, immune activators, and tumor microenvironment conditioning agents.
Contact Information
- Headquarters
- 3 Forbes RdLEXINGTON, MA, United States 02421-7305
- Phone
- 781-674-4400
- Fax
- 781-674-4200
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Garo Armen
- Vice President - Finance
- Christine Klaskin
- Chief Medical Officer
- Steven O'Day
- Head of Regulatory
- Eric Olson
- Lead Independent Director
- Timothy Wright
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $97.7M |
|---|---|
Revenue (TTM) | $159.6M |
Shares Outstanding | 21.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.36 |
EPS | $-11.27 |
Book Value | $-8.13 |
P/E Ratio | -0.4x |
Price/Sales (TTM) | 0.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -71.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
